Clinical Trial Update: The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of allogenic stem cells after traditional treatment for osteochondral lesions of the talus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteochondral Fracture of Talus
• Osteochondral Lesion of Talus

Drugs mentioned

• Allogenic stem cells

Snippet

Sponsor: University of Chile | Conditions: Osteochondral Fracture of Talus | Phase 3 | Status: UNKNOWN